Plain-English translation of NCT04743102 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
After you receive chemotherapy and radiation for rectal cancer, doctors need to know whether the cancer has completely gone away before deciding on surgery. Right now, doctors use physical exams, blood tests, and imaging scans to make this decision โ but these methods aren't always accurate. This trial is testing whether taking small tissue samples (biopsies) from multiple spots in the rectum, including deeper layers, can give doctors a clearer picture of whether the cancer has truly disappeared.
Currently, doctors cannot reliably tell which patients have complete remission of rectal cancer before surgery. Some patients may have surgery when they don't need it, while others might miss cancer that's still present. This study aims to improve how accurately doctors can detect whether the cancer is truly gone, so you can get the right treatment plan.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will undergo standard exams (digital rectal exam, blood tests, MRI, and endoscopy) to see if your cancer has responded to treatment. If you qualify, you will be randomly assigned to one of two groups: one group will receive the standard evaluation only, and the other group will also have small tissue biopsies taken from several spots in the rectum during endoscopy. After this evaluation, you will proceed to surgery as planned. The biopsies help doctors confirm whether the cancer is truly gone before your operation.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
China